“Vortioxetine Improves Gastrointestinal Motility and Reduces Intestinal Inflammation in a Cuprizone-Induced Multiple Sclerosis Model in Mice”. Annals of Medical Research 33, no. 5 (May 22, 2026): 192–198. Accessed June 1, 2026. http://www.annalsmedres.org/index.php/aomr/article/view/4909.